#Fsmp among us
Explore tagged Tumblr posts
Text
Helix stimboard
may cause unwanted stimming
tw: flashing lights
#fable smp#fsmp#Fable smp among us#among us#Fsmp among us#among us au#Helix#Ye#visual stim#stim gifs#stimboard#stimblr#stimmy#stimboards#Stims#sensory#does this make sense#Lil engineer#icarus#icarus fable smp#icarus morningstar#uhhhh#fuble#sqcu#sherbverse#sqcu roleplay#sherbertquake56#sherbertverse
9 notes
·
View notes
Text
Theia Sorin, engineer of Lodestar
222 notes
·
View notes
Note
What hozier songs would fit your characters?
OH GOD DON’T GET ME STARTED, IM HOZIER FAN NO.1—
FSMP!Ven is Run — this song is about how Ireland destroys its own civilians, a nation betraying its own people. And c!Ven’s part of the system that destroyed the people of the realms. It’s really interesting bc the original quote that Hozier took to create this song, from James Joyce— “Do you know what Ireland is?’ asked Stephen with cold violence. ‘Ireland is the old sow that eats her farrow.” — frames Ireland’s destruction as a little bit loving, from a motherly figure. c!Ven did what he did out of love, and he was misled through parts of it aswell. It’s destruction for a misled “greater good,” and that’s c!Ven’s rotten core. (BUT i will also say, From Eden was the thing that inspired vengári, so credit where credit is due there, i love that song for him too <3 )
Evan (AmongUs! Ven) is Sunlight — whilst there’s been less content of him than most Ven varients, i’d describe him as kind and emotion driven even when it’s not smart to be. He’d defy or kill his boss if it meant his boyfriend surviving and thriving, and that’s the extremism that’s portrayed in Sunlight.
Marcel is I, Carrion (Icarian) — I think this one’s pretty self-explanatory, but it’s about how Marcel has been uplifted by love his whole life. Yes he’s been through things, but he’s been loved through all of them. It’s also very Lovebirds coded heheh. But will love be enough in the end for Marcel?
Nephrus is Unknown/Nth — This one was actually so hard to pick but i’m gonna settle for this. The most heartbreaking thing about Neph is that he’s never been known. Through his childhood, his young friendships, the times he’s been betrayed or treated like shit, all of those people didn’t care enough to know who Neph was. He’s been tricked all throughout his life. (I also think Run works for Neph too, since he’s the one being betrayed by his leaders. and bonus: Too Sweet is THEE Danphrus song and Wasteland, baby!)
and,,,, secret option from the guy who’s barely been introduced—
Agent Altas (c!Ven) is Arsonist’s Lullaby — this song is about being called to something, and not knowing why or how, and following the feeling until it brings you to destruction or destiny. Having a predetermined path you must follow. That’s Ven to a T. (this guy’s hardly been seen —asside from Fable survival games and one or two appearances other places, but trust me this guy is cool. content will come out about him soon (hopefully,,, IRL life has been crazy for me lately lol))
anyways hope y’all enjoyed the yap <3
#fsmp#fable smp#cantripped#cantripped nephrus#cantripped podcast#boundsmp marcel#vengári#boundsmp#ven asks#fablesmp#among us ven
73 notes
·
View notes
Text
I am tempted
Tempted to write a prison duo among us au oneshot
But
But like
Parasite
Mmmm parasite
Mmmmmm first kiss when one is dying in the others arms as the infected finally break through the infection for a split second to say goodbye
Mmm
#fable smp#fablesmp#fablesmpblr#fsmp#fsmpblr#fable smp among us#fable smp prison duo#prison duo#Ferals chatter🪿
70 notes
·
View notes
Text
I don’t understand how I have I have so much vitriol towards fable, but so much love for fuble, like, he’s just an ethically questionable silly goofy CEO
84 notes
·
View notes
Text
One of my proudest accomplishments was coming up with the name "shercurity" during that one fable among us stream.
80 notes
·
View notes
Text
I have a wet birds fic already in progress but I'm definitely going to write an Evan and Helix Among us au fic where they're shuttle pod crash lands on the Fungle map so we can have a crush confession on the beach it's going to be pure fluff.
52 notes
·
View notes
Text
A bit of fluff before the finale, mayhaps?
Roughly 500 words-
20 notes
·
View notes
Text
I know everyone is fulfilling their bribes from the poll(tm) right now, which prison duo rightfully won. But I have a little among us wet birds fic that tickles my brain, and I need people to tell me what to do because decisions are hard :P
13 notes
·
View notes
Text
GLOBAL TRADE: Safer labelling on baby foods and drinks urgently needed
IBFAN FUF comment
IBFAN RUTF comment
IBFAN COMMENT FOPN
IBFAN ENCA CRD 46th CCFL 3
Governments must take the lead on public health policies: Safer labelling for baby drinks and foods urgently needed.
46th Codex Committee on Food Labelling
IBFAN will be attending the Codex meeting on labelling – Monday 27th September- 7th October (and the webinar on Front of Pack Labelling 21-22 September).
Agenda Item 4 includes two important labelling decisions carried over from the Nutrition meeting (CCNFSDU) Proposed Draft revised standard for Follow-up Formula (see FUF comments) and the Guidelines on Ready to Use Therapeutic Foods (see RUTF comments)
IBFAN PROPOSAL
Follow-up formulas and Drinks for Young Children are used and regulated as breastmilk substitutes in many countries so the standard should be aligned as far as possible with the WHO policy, including the ban on cross promotion, a deceptive tactic that misleads parents and carers. The term ‘refer to’ is not enough to stop products appearing similar.
9.6.5 The labelling of the product as defined in Section 2.1 shall not refer to OR RESEMBLE infant formula, follow-up formula for older infants, or formula for special medical purposes intended for infants, including numbers, text, statements, or images of these products.
Alternatively:
The labelling of the product as defined in Section 2.1 shall not CROSS PROMOTE infant formula, follow-up formula for older infants, or formula for special medical purposes intended for infants, including numbers, text, statements, or images of these products.
__________________________________________________________________
PROPOSED DRAFT GUIDELINES FOR READY TO USE THERAPEUTIC FOODS (RUTF)
The current draft guidelines refer only to the weak labelling safeguards for Foods for Special Medical Purposes (FSMPs) – products that are on general sale. Claims are MARKETING TOOLS that are not appropriate for therapeutic foods. WHA Resolution 63.23 forbids health or nutrition claims on foods for infants and young children.
IBFAN PROPOSAL for RUTF label:
Section 12 must include the following text:
It is recommended that the labelling of RUTF for children from 6 to 59 months with SAM be in accordance with the Standard for the Labelling of and Claims for Foods for Special Medical Purposes (CXS 180-1991), the General Standard for the Labelling of and Claims for Pre-packaged Foods for Special Dietary Uses (CXS 146-1985), and Guidelines on Nutrition Labelling (CXG 2-1985)..and the Guidelines for Use of Nutrition and Health Claims (CXG 23-1997) that include a prohibition on the use of nutrition and health claims for foods for infants and young children.
There should be the following prominent WARNINGS:
This product must only be used for the therapeutic treatment of Severe Acute Malnutrition, strictly under medical supervision
Potable drinking water must be available for children receiving RUTF treatment.
Not for general sale
Useful links:
Exporting countries put trade before the health of the planet and children. IBFAN Press release, Nov 2019
WHO/UNICEF INFORMATION NOTE – Cross–promotion of infant formula and toddler milks, WHO, 2018).
Worldwide Baby Food Drink Market In-depth Research Report 2021, Forecast to 2026, expects 7.7% growth from $68bn in 2020 to 91bn by 2026 – more than 30% in 5 years!
_________________________________________
IBFAN ENCA CRD CCFL
IBFAN Brief in spanish
_________________________________________________________________________________
CODEX COMMITTEE ON FOOD LABELLING (CCFL)
PROPOSED DRAFT GUIDELINES ON FRONT–OF–PACK NUTRITION LABELLING (CX/FL 21/46/6 June 21)
(Prepared by the Electronic Working Group Chaired by Costa Rica and Co–chaired by New Zealand
IBFAN is advocating that FOPNL should NOT appear on products 0-36 months. WHO guiding principles and framework manual for front-of- pack labelling for promoting healthy diets recommend excluding baby foods on the basis that since FOPL schemes – unless restricted to warnings – are promotional and this would be against WHO policy that forbids promotion and any health and nutrition claims for such products. Concerns about high levels of problematic ingredients (sugar, salt fat etc) are better handled through limits set by Codex or national legislation. FOPL is designed for the general population , not for specific categories of foods.
The proposals should be government-led with adequate COI and transparency safeguards. There should be no reference to ‘collaboration with the Private sector’ since this could imply inappropriiate influence of the policy setting process.
It is not MANDATORY for any country to adopt a Codex text – countries are, however, expected to use them as a basis for legislation and not be more trade restrictive than necessary. If a Codex standard does not allow a country to achieve its public health objective effectively the government can go further.
IBFAN COMMENT FOPN
Posición-IBFAN Spanish
46th Codex Committee on Food Labelling cl21_19e. CLICK HERE for report CX/FL 21/46/627 September–1 October and 7 October 2021
Please share IBFAN’s comments on both these items your government delegations in the hopes that they can take our concerns into account.
WHO guiding principles and framework manual for front-of- pack labelling for promoting healthy diets
_______________________________________________________
CODEX COMMITTEE ON NUTRITION (CCNFSDU)
PROPOSED DRAFT GUIDELINES FOR READY TO USE THERAPEUTIC FOODS (RUTF)
IBFAN comment RUTF
_________________________________________________________________-
DRAFT REVISED STANDARD FOR FOLLOW-UP FORMULA (CXS 156-1987) SECTION B: DRINK/PRODUCT FOR YOUNG CHILDREN WITH ADDED NUTRIENTS OR DRINK FOR YOUNG CHILDREN
IBFAN Step 7 FUF
ENCA- Codex FUM section B
Here in Spanish: Posición IBFAN en Codex 2021
____________________________________________________________________
IBFAN COMMENT PROPOSED DRAFT GUIDELINES ON FRONT-OF-PACK NUTRITION LABELLING at Step 3 – submitted 1st September 2021
General Comments
Front of Pack Nutrition Labeling (FOPNL) can be a means to provide additional information to those who purchase pre-packaged foods and provide a system for making decisions about food products available in the market-place. Moreover it has the potential of reducing consumption of food ingredients and products that contribute to unhealthy diets.
A number of underlying principles are essential for the effective implementation of FOPNL policies.
For FOPNL to be effective IBFAN considers a mandatory system of WARNINGS to be much preferred. Research of countries where FOPNL has been voluntary shows limited uptake by the food products industries and hence the ability for product comparisons is compromised and the expected health benefits are under realized.
Processed complementary food products and formulas for infants and young children should not have FOPNL as this will be promotional of certain products over other products and contrary to the provisions of the International Code of Marketing of Breastmilk Substitutes and subsequent WHA resolutions. To effectively safeguard infant and young child health, it is preferable to have warnings on these products.
Codex must address the environmental impact of the global trade in unnecessary food products. The United Nations Intergovernmental Panel on Climate Change (IPCC) estimates that 21–37% of total greenhouse gas (GHG) emissions are attributable to the food system and that climate change will have important negative impacts on food security. Green lighting the ultra-processed, excessively packaged with plastic/styrofoam products may reduce the consumption of a few harmful food ingredients yet will continue contributing to increasingly alarming levels of environmental degradation.
In view of the need to safeguard policy setting from commercial influence, IBFAN believes that the business term ‘stakeholder’ is removed from all Codex texts. Advocating for public health goals/objectives is very different from seeking commercial/profit ones. It is misleading to group all constituents under this term.
Specific Comments
It is critical that the implementation and policy setting for FOPNL be led by national governments who are accountable and responsible for the overall health and nutrition of their citizens. To fulfill their obligations governments must ensure that policy development is free of commercial influence while ensuring adequate participation from civil society, independent academics, health associations, and other relevant constituencies.’
We see no need for a Codex text to list collaboration or consultation with specific interested parties since this is likely to open the door to abuse and legitimise corporate lobbying – placing the businesses on the same level as all other actors. Governments have a duty to protect citizens and ensure appropriate consultations.
Principle 4.3.1 The text should. read:
FOPNL should be government led and developed in collaboration with all interested parties including government, consumers, academia, public health associations, private sector among others, by ensuring robust safeguards against conflict of interest.
Section 2.2 Exclusion for foods and products intended for infants and / or young children
Commercial foods and products intended for infants and young children should not be included in the guidelines for FOPNL. The International Code of Marketing of Breastmilk Substitutes and subsequent resolutions of the World Health Assembly govern the labeling and marketing of a number of these products. These include infant formulas, formulas for special medical purposes, follow-up formulas and drinks for young children. A number of Code provisions also cover complementary foods for older infants and young children. Claims are not permitted by Codex Guidelines on Nutrition and Health Claims or WHA Resolution 63.23 that urges Member States “To end inappropriate promotion of foods for infants and young children and to ensure that claims not be permitted for foods for infants and young children”
The FOPNL would be contrary to provisions in the International Code as they are promotional in essence by preferring one product to another. This may lead parents and care givers to perceive these products as being endorsed by government authorities and thus have a negative impact on breastfeeding decision-making. In effect FOPNL on formulas for infants and children will have a negative impact on infant and young child health.
Similarly complementary food products should not be included. These products are highly processed and their consumption should be discouraged. Older infants and young children fed processed complementary foods risk dental caries, obesity and develop preferences for bland “white” foods. Ultra-processed products invariably contain chemical additives to stabilize, emulsify, thicken, regulate acidity, and act as anti-oxidants etc. Many ingredients are “permitted” by Codex Alimentarius standards, some at regulated levels and others according to “good manufacturing practices”, with their safety declared not by independent and convincing science but on the basis of political consensus and claims of “history of safe use”.
Public health nutrition policy promotes the consumption of healthy nutritious foods for optimal health and development as well as the development of life long preferences for healthy foods. FOPNL in these situations can act as a marketing tool for the consumption of inappropriate ultra-processed food products at a vulnerable stage of growth and development.
IBFAN COMMENT ON FOPL IN SPANISH
POSICIÓN DE IBFAN
BORRADOR DE PROPUESTA SOBRE ETIQUETADO DE NUTRICIÓN EN EL FRENTE DEL ENVASE (ETIQUETADO FRONTAL)
Paso 3
Observaciones generales
(1 de set. 2021 – Equipo de trabajo IBFAN sobre Codex Alimentarius, Adaptada al español por la Coordinación IBFAN LAC)
El etiquetado frontal (FOPNL por sus siglas en inglés) puede ser un medio para proporcionar información adicional a quienes compran alimentos pre-envasados ofreciendo así, un sistema para tomar decisiones sobre los productos alimenticios disponibles en el mercado. Además, este etiquetado tiene el potencial de reducir el consumo de ingredientes alimenticios y productos que contribuyen a dietas poco saludables.
Una serie de principios subyacentes son esenciales para la implementación efectiva de las políticas de FOPNL. Para que el FOPNL sea efectivo, IBFAN propone un sistema OBLIGATORIO de ADVERTENCIAS. La investigación muestra que en los países donde el FOPNL ha sido voluntario, las industrias de productos alimenticios han aceptado el etiquetado de manera limitada, y por lo tanto, la capacidad de comparación entre productos se ha visto comprometida y no se dan los beneficios esperados para la salud.
Los productos infantiles complementarios procesados y las fórmulas para lactantes y niños de corta edad no deben tener FOPNL, ya que esto sería promocionar ciertos productos sobre otros, y sería contrario a las disposiciones del Código Internacional de Comercialización de los Sucedáneos de la Leche Materna y las Resoluciones posteriores de la AMS. Para salvaguardar eficazmente la salud de lactantes y niños pequeños, es preferible tener ADVERTENCIAS sobre estos productos.
Por otro lado, el Codex debe abordar el impacto ambiental del comercio mundial de los productos alimenticios innecesarios. El Grupo Intergubernamental de Expertos sobre el Cambio Climático (IPCC) de las Naciones Unidas estima que entre el 21% y el 37% de las emisiones totales de gases de efecto invernadero (GEI) son atribuibles al sistema alimentario y que el cambio climático tendrá importantes impactos negativos sobre la seguridad alimentaria. Iluminar con color verde los productos ultraprocesados – de todas maneras, envasados excesivamente con plástico / espumas de poliestireno, etc – podrá reducir el consumo de algunos ingredientes alimentarios dañinos, pero no hará que estos productos dejen de ser contribuyentes a los niveles cada vez más alarmantes de degradación ambiental.
En vista de la necesidad que tenemos de proteger que las políticas se definan sin influencia comercial, IBFAN cree que el término “partes interesadas o asociadas” es de corte comercial y por lo tanto, debe eliminarse de todos los textos del Codex. Abogar por metas/objetivos de salud pública es muy diferente a buscar metas comerciales o lucrativas. Es entonces engañoso agrupar a todos los constituyentes bajo el mismo término de “partes interesadas o asociadas
Comentarios específicos
Es fundamental que la implementación y el establecimiento de políticas de FOPNL sea un proceso liderado por los gobiernos nacionales ya que éstos son los responsables de la salud y de la nutrición general de su ciudadanía. Para cumplir con sus obligaciones, los gobiernos deben garantizar que el desarrollo de las políticas públicas esté libre de influencia comercial, al tiempo que deben garantizar la participación adecuada de la sociedad civil, la academia independiente, las asociaciones de salud y otros grupos relevantes.
Por lo anterior, no vemos la necesidad de un texto del Codex que enumere la colaboración o la consulta con partes interesadas específicas, ya que esto muy probablemente abriría un portillo al abuso y legitimación del cabildeo que realizan las corporaciones y colocaría a las empresas al mismo nivel que los demás actores que velan por la salud pública. Los gobiernos tienen el DEBER de proteger a su ciudadanía y de garantizar las consultas apropiadas.
Principio 4. 3. 1 Por lo anterior, el texto debe decir:
El FOPNL debe ser dirigido y desarrollado por el gobierno en colaboración con todas las partes interesadas, incluidos el gobierno, los consumidores, la academia, las asociaciones de salud pública, el sector privado, entre otros, asegurando salvaguardias sólidas contra los conflictos de interés.
Sección 2.2 Exclusión de los alimentos y productos destinados a lactantes y/o niños de corta edad
Los alimentos y productos comerciales destinados a bebés y niños pequeños no deben incluirse en las directrices de FOPNL.
El Código Internacional de Comercialización de Sucedáneos de la Leche Materna y las Resoluciones posteriores de la Asamblea Mundial de la Salud rigen el etiquetado y la comercialización de muchos de estos productos. Están incluidas las fórmulas infantiles, fórmulas con fines médicos especiales, fórmulas de seguimiento y bebidas para niños pequeños. Varias disposiciones del Código también abarcan los alimentos complementarios para lactantes mayores y niños de corta edad.
Las declaraciones de propiedades saludables y nutricionales no están permitidas por las Directrices del Codex sobre Nutrición y Salud y por la Resolución 63.23 de la Asamblea Mundial de la Salud, que insta a los Estados Miembros a poner fin a la promoción inadecuada de alimentos para lactantes y niños de corta edad y a garantizar que no se permitan las declaraciones de propiedades saludables en los alimentos para lactantes y niños de corta edad. Por lo anterior, el FOPNL sería contrario a las disposiciones del Código Internacional, ya que en esencial, es un etiquetado promocional que preferiría un producto sobre otro producto. Esto puede llevar a las madres, padres y cuidadores a la percepción de que estos productos están respaldados por las autoridades gubernamentales y, por lo tanto, tendrían un impacto negativo en la toma de decisiones sobre la lactancia materna. En efecto, el FOPNL en las fórmulas infantiles tendría un impacto negativo en la salud de los bebé y niños pequeños.
Del mismo modo, el FOPNL no debe incluirse en los productos infantiles alimenticios complementarios. Estos productos son altamente procesados, innecesarios y su consumo debe ser desalentado. Bebés mayores y niños pequeños alimentados con alimentos complementarios procesados corren el riesgo de caries dental, obesidad y desarrollan preferencias por alimentos “blancos” suaves. Los productos ultraprocesados invariablemente contienen aditivos químicos para estabilizar, emulsionar, espesar, regular la acidez y actuar como antioxidantes, etc. Muchos de estos ingredientes están “permitidos” por las normas del Codex Alimentarius, algunos están en algún nivel regulados y otros dejados a en las manos de las “buenas prácticas de fabricación”, con una declaración de seguridad – no basada en la ciencia independiente y basada en evidencia- sino en un consenso político y de “historia de uso seguro”.
La política de nutrición de salud pública promueve el consumo de alimentos nutritivos saludables para la salud y desarrollo óptimo, así como el desarrollo de preferencias de alimentos saludables, de por vida. Dadas las circunstancias, el FOPNL podría convertirse en una herramienta de marketing que incentiva el consumo de productos infantiles ultraprocedados e inapropiados, en una etapa vulnerable de crecimiento y desarrollo infantil.
____________________________________________________________________-
GLOBAL TRADE: Safer labelling on baby foods and drinks urgently needed was originally published on Baby Milk Action
2 notes
·
View notes
Text
Food for Special Medical Purpose (FSMP) Market Drivers, Restraints, Key Factors Forecast, 2020–2027
The global Food for Special Medical Purpose (FSMP) market report analyzes the current trends of the market along with the market size, market share, revenue growth, and overall industry overview. The report aims to shed light on the prevalent business strategies and models, analyse the market trends, and investigate the growth of the market through thorough statistical analysis. The report also covers SWOT analysis, Porter’s Five Forces analysis, feasibility analysis, and investment return analysis. The report aims to provide strategic recommendations to key players and new entrants to help them gain a robust footing in the market.
The market offers key insights into the historical and current data with regards to market size and volume depending on the key companies, major geographies, product types, application, consumer base, and manufacturing and production pricing. The report offers insights into key drivers and growth opportunities the market is expected to witness over the forecast period.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/59
The food and beverage industry is majorly driven by rapid technological advancements and increasing number of collaborations and partnerships in the market. Development of innovative food products such as plant-based meat, faux burgers, and functional foods is expected to further accelerate the revenue growth of the market over the forecast period. Increasing changes in the dietary habits and food consumption due to the COVID-19 pandemic has significantly altered the dynamics of the market.
In addition, to meet the growing consumer demand key manufacturers are improving their transparency of their supply chains and products. Rising demand for clean labels and ethical ingredients has prompted the key food manufacturers to bring about innovation in their product portfolio and manufacturing processes. The report also sheds light on the recent technological and process development, mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, and brand promotion and product launches, among others.
Major Players Operating in Global Food for Special Medical Purpose (FSMP) Market:
Nestle
Danone Nutricia
Abbott
Bayer
MeadJohnson
Ajinomoto
BOSSD
LESKON
EnterNutr
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/59
Market Segmentation:
By Type (Revenue, USD Million; Volume in Tons, 2017–2027)
Nutritionally Complete Foods
Nutritionally Complete Foods with a Disease
Nutritionally Incomplete Foods
By Application Type (Revenue, USD Million; Volume in Tons, 2017–2027)
Infants and Young Children
Adult
The Old
Based on region, the global Food for Special Medical Purpose (FSMP) market has been segmented into five major geographies of the world including North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. In this section, the report offers key insights into market size, market share, market revenue, production and consumption patterns, import/export, supply and demand ratio, consumer demand, and presence of key companies in each region.
To know more about the report @ https://www.reportsanddata.com/report-detail/food-for-special-medical-purpose-fsmp-market
Key Highlights in the Report:
Provides a detailed overview of market growth and patterns for the years 2021-2028, including key market parameters.
It provides useful information about the global Food for Special Medical Purpose (FSMP) industry, including market forecasts and sales growth rates.
Technical advances, regulatory environment, recent innovations, and existing and emerging trends in the Food for Special Medical Purpose (FSMP) market are all covered in this report.
Comprehensive industry analysis, including key statistical data and market knowledge gleaned from primary and secondary research.
Thank you for reading our report. To know more about the customization of the report, please get in touch with us and our team will ensure the report is suited to your requirements.
Browse More Related Report:
1. Diphenylamine Market
2. Cervical Interbody Fusion Cages Market
3. PVDC Resins & PVDC Latex Market
4. Large-scale Reed Switch Market
5. Telematics Control Unit Market
#Food for Special Medical Purpose (FSMP) Market#Food for Special Medical Purpose (FSMP) Market trends#Food for Special Medical Purpose (FSMP) Market size
0 notes
Link
Foods for special medical purposes (FSMP) are a sub-category of foods intended for particular nutritional uses (PARNUT), also called “dietetic foods.” FSMPs are intended for the dietary management of diseases in patients with impaired digestive function such as absorption, making them the most medically-oriented food category. The Asia-Pacific Food for Special Medical Purpose (FSMP) market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Food for Special Medical Purpose (FSMP) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
0 notes
Text
Global Food For Special Medical Purpose Market: Analysis, Technologies, Forecasts and Applications: Infants & Young Children, Adult, The Old
Food For Special Medical Purpose Market Report:
Summary: Excellence consistency maintains by Garner Insights in Research Report in which studies the global Food For Special Medical Purpose market status and forecast, categorizes and Equipment market value by manufacturers, type, application, and region.Over the next five years, LPI(LP Information) projects that Food for Special Medical Purpose (FSMP) will register a 5.7% CAGR in terms of revenue, reach US$ 14800 million by 2023, from US$ 10600 million in 2017. The report on Global Food For Special Medical Purpose Market studies the historical data and evaluates the current market scenario so as to project the flight of the market during the next couple of years. This study has been collated using primary and secondary research methodologies that are meant to provide the users a detailed view of the major aspects of the market. The report also takes into consideration the different strategies, emerging technologies, collaborations, product launches, and mergers & acquisitions, in order to carry out a detailed analysis of the market.
Request for Sample PDF Brochure @:- http://garnerinsights.com/2018-2023-Global-Food-for-Special-Medical-Purpose-FSMP-Consumption-Market-Report#request-sample
Scope of the Research:
Ø Current market size for 2018 and forecast till 2023
Ø Strategic analysis and market focus
Ø Latest industry-specific trends and the technological advancements
Ø Market developments covering M&A, investment, funding, partnerships, collaborations, etc.
Ø Competitive landscape analysis
Ø Continue…
Some of the key regions covered in the market:
I.North America (U.S and Canada and rest of North America)
II.Europe (Germany, France, Italy and Rest of Europe)
III.Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
IV.LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)
GET Special Discount @:- http://garnerinsights.com/2018-2023-Global-Food-for-Special-Medical-Purpose-FSMP-Consumption-Market-Report#discount
Global Food For Special Medical Purpose Market Segmented by Types:- Nutritionally Complete Foods, Nutritionally Complete Foods with a Disease, Nutritionally Incomplete Foods.
Global Food For Special Medical Purpose Market competition by top manufacturers/players:- Nestle, Danone Nutricia, Abbott, Bayer, MeadJohnson, Ajinomoto, BOSSD, LESKON, EnterNutr.
Applications analyzed in this report are:- Infants & Young Children, Adult, The Old.
The report also presents a thorough qualitative and quantitative data pertaining to the projected impact of these factors on market’s future growth prospects. With the inclusive market data concerning the key elements and segments of the global Food For Special Medical Purpose market that can influence the growth prospects of the market, the report makes for a highly informative document.
Report Highlights:
Ø The report provides a detailed survey of the current and future industry trends so as to identify the investment analysis.
Ø The industry forecasts, using estimated market values have been mentioned, till 2023.
Ø Market dynamics such as the drivers, restraints, threats, opportunities, and industry-specific challenges
Ø Key industry trends across all the market segments and sub-segments, geographies, and nations.
Ø Key developments and strategies determined in the market.
Ø Detailed profiling of the leading competitors and the entrant market players.
Ø Growth prospects among the emerging nations throughout the forecast period.
Ø Market opportunities and recommendations for new investments.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like Asia, United States, Europe.
About Garner Insights:
Garner Insights is a Market Intelligence and consulting firm with an all-inclusive experience and vast knowledge of the market research industry.Our vast storage of research reports across various categories, gives you a complete view of the ever changing and developing trends and current topics worldwide. Our constant endeavor is to keep on improving our storage information by providing rich market reports and constantly improving them.
Contact Us: Mr. Kevin Thomas Direct: +1 513 549 5911 (US) +44 203 318 2846 (UK) Email: [email protected]
from Blogger https://ift.tt/2OvY7ZH via IFTTT
0 notes
Text
I genuinely don't know if I've posted my writing before so this is ✨ scary✨
But anyways among us au (read tws, very important)
23 notes
·
View notes
Link
Foods for special medical purposes (FSMP) are a sub-category of foods intended for particular nutritional uses (PARNUT), also called “dietetic foods.” FSMPs are intended for the dietary management of diseases in patients with impaired digestive function such as absorption, making them the most medically-oriented food category. Scope of the Report: This report focuses on the Food for Special Medical Purpose (FSMP) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Nestle Danone Nutricia Abbott Bayer MeadJohnson Ajinomoto BOSSD LESKON EnterNutr Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Nutritionally Complete Foods Nutritionally Complete Foods with a Disease Nutritionally Incomplete Foods Market Segment by Applications, can be divided into Infants & Young Children Adult The Old There are 15 Chapters to deeply display the global Food for Special Medical Purpose (FSMP) market. Chapter 1, to describe Food for Special Medical Purpose (FSMP) Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Food for Special Medical Purpose (FSMP), with sales, revenue, and price of Food for Special Medical Purpose (FSMP), in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Food for Special Medical Purpose (FSMP), for each region, from 2012 to 2017; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017; Chapter 12, Food for Special Medical Purpose (FSMP) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022; Chapter 13, 14 and 15, to describe Food for Special Medical Purpose (FSMP) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
#(north america#asia-pacific#america#and africa) food special medical purpose (fsmp) market#and africa) food special medical purpose (fsmp) market trends#and africa) food special medical purpose (fsmp) market size#and africa) food special medical purpose (fsmp) market data#and africa) food special medical purpose (fsmp) market structure#and africa) food special medical purpose (fsmp) industry analysis#and africa) food special medical purpose (fsmp) market research
0 notes
Text
Food for Special Medical Purpose (FSMP) Market Size, Industry Analysis & Forecast Report 2017
ReportsMonitor.com has added a new report to its database Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Food for Special Medical Purpose (FSMP) Market 2017 Forecast to 2022.
This report identifies the Food for Special Medical Purpose (FSMP) market size for the years 2012-2017, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the Food for Special Medical Purpose (FSMP) market.
Food for Special Medical Purpose (FSMP) Market tracks the major market events including product launches, technological developments, mergers and acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Copper Strips market. This research report offers in-depth analysis of the market size (revenue), market share, major market segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges.
For Requesting a Sample Copy of This Report, Please Visit @ http://ift.tt/2xAOYHS
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Nestle
Danone Nutricia
Abbott
Bayer
MeadJohnson
Ajinomoto
BOSSD
LESKON
EnterNutr
The competitive landscape of the global market for Food for Special Medical Purpose (FSMP) is determined by evaluating the various market participants, production capacity, Food for Special Medical Purpose (FSMP) market’s production chain, and the revenue generated by each manufacturer in the Food for Special Medical Purpose (FSMP) market worldwide.
This report segments the Food for Special Medical Purpose (FSMP) market
Nutritionally Complete Foods
Nutritionally Complete Foods with a Disease
Nutritionally Incomplete Foods
On the basis of application:
Infants & Young Children
Adult
The Old
For comprehensive understanding of market dynamics, the Food for Special Medical Purpose (FSMP) market is analyzed across key geographies namely:
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Browse Full Table of Contents and Report Description @ http://ift.tt/2ytsgAM
There are 15 Chapters to deeply display the global Food for Special Medical Purpose (FSMP) market.
Chapter 1, to describe Food for Special Medical Purpose (FSMP) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Food for Special Medical Purpose (FSMP), with sales, revenue, and price of Food for Special Medical Purpose (FSMP), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Food for Special Medical Purpose (FSMP), for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Food for Special Medical Purpose (FSMP) market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Food for Special Medical Purpose (FSMP) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
About Us: Reports Monitor (ReportsMonitor.com) is a platform to meet the market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. We have a vast collection of reports, covering maximum industries worldwide. Our process is meticulously planned and executed in order to use maximum resources and explore the market for getting genuine insights. Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.
Contact Us: Jay Matthews Direct: +1 513 549-5911 Email: [email protected] Website: http://ift.tt/2majIg1
Follow Us: Google plus: http://ift.tt/2psfqSW Twitter: https://twitter.com/reportsmonitor Face book: http://ift.tt/2oAJVm6
0 notes